Kathryn Romano, Chief Accounting Officer at Krystal Biotech, Inc. ($KRYS), sold shares on the open market eight times over the last year, totaling $3.6 million. Her most recent sale occurred on March 2, 2026. These transactions rank her 2,398th among 11,678 insiders in our database by sale value, below the average of $8.6 million across 6.4 transactions per insider. She made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 27, 2026 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | A | Restricted Stock Units | 5442 | $0.00 | 5,442.0000 | 29,951,000 | 9999.99% | 0.02% |
| Feb. 27, 2026 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 7500 | $0.00 | 26,068.0000 | 29,951,000 | 40.39% | 0.03% |
| Feb. 27, 2026 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | F | Common Stock | 3262 | $275.64 | 22,806.0000 | 29,951,000 | 12.51% | 0.01% |
| Feb. 27, 2026 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 550 | $0.00 | 23,356.0000 | 29,951,000 | 2.41% | 0.00% |
| Feb. 27, 2026 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | F | Common Stock | 240 | $275.64 | 23,116.0000 | 29,951,000 | 1.03% | 0.00% |
| March 2, 2026 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 750 | $267.60 | 22,366.0000 | 29,951,000 | 3.24% | 0.00% |
| Feb. 27, 2026 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Performance Stock Units | 7500 | $0.00 | 0.0000 | 29,951,000 | 100.00% | 0.03% |
| Feb. 27, 2026 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Restricted Stock Units | 550 | $0.00 | 1,650.0000 | 29,951,000 | 25.00% | 0.00% |
| Feb. 27, 2026 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | A | Stock Option (Right to Buy) | 13575 | $0.00 | 13,575.0000 | 29,951,000 | 9999.99% | 0.05% |
| Feb. 9, 2026 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 12500 | $63.55 | 31,818.0000 | 29,951,000 | 64.71% | 0.04% |
| Feb. 9, 2026 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 29,951,000 | 50.00% | 0.04% |
| Feb. 9, 2026 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | G | Common Stock | 750 | $0.00 | 18,568.0000 | 29,951,000 | 3.88% | 0.00% |
| Feb. 9, 2026 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 96 | $277.88 | 19,318.0000 | 29,951,000 | 0.49% | 0.00% |
| Feb. 9, 2026 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 400 | $275.68 | 19,414.0000 | 29,951,000 | 2.02% | 0.00% |
| Feb. 9, 2026 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 552 | $274.64 | 19,814.0000 | 29,951,000 | 2.71% | 0.00% |
| Feb. 9, 2026 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 928 | $273.71 | 20,366.0000 | 29,951,000 | 4.36% | 0.00% |
| Feb. 9, 2026 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 2824 | $272.51 | 21,294.0000 | 29,951,000 | 11.71% | 0.01% |
| Feb. 9, 2026 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 5700 | $271.66 | 24,118.0000 | 29,951,000 | 19.12% | 0.02% |
| Feb. 9, 2026 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 2000 | $270.56 | 29,818.0000 | 29,951,000 | 6.29% | 0.01% |
| Feb. 28, 2025 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Performance Stock Units | 7500 | $0.00 | 7,500.0000 | 29,740,000 | 50.00% | 0.03% |
| Feb. 28, 2025 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Performance Stock Units | 5000 | $0.00 | 0.0000 | 29,740,000 | 100.00% | 0.02% |
| Feb. 28, 2025 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | F | Common Stock | 3471 | $179.25 | 19,318.0000 | 29,740,000 | 15.23% | 0.01% |
| Feb. 28, 2025 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 7500 | $0.00 | 22,789.0000 | 29,740,000 | 49.05% | 0.03% |
| Feb. 28, 2025 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | F | Common Stock | 2315 | $179.25 | 15,289.0000 | 29,740,000 | 13.15% | 0.01% |
| Feb. 28, 2025 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 5000 | $0.00 | 17,604.0000 | 29,740,000 | 39.67% | 0.02% |
| Feb. 27, 2025 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 750 | $175.22 | 12,604.0000 | 29,740,000 | 5.62% | 0.00% |
| Feb. 28, 2025 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | A | Restricted Stock Units | 2200 | $0.00 | 2,200.0000 | 29,740,000 | 9999.99% | 0.01% |
| Feb. 26, 2025 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | F | Common Stock | 2268 | $176.39 | 13,354.0000 | 29,740,000 | 14.52% | 0.01% |
| Feb. 28, 2025 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | A | Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 29,740,000 | 9999.99% | 0.03% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 100 | $166.22 | 12,936.0000 | 27,752,000 | 0.77% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 700 | $63.55 | 13,636.0000 | 27,752,000 | 5.41% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 700 | $168.91 | 12,936.0000 | 27,752,000 | 5.13% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 203 | $63.55 | 13,139.0000 | 27,752,000 | 1.57% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 203 | $169.47 | 12,936.0000 | 27,752,000 | 1.55% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 100 | $63.55 | 13,036.0000 | 27,752,000 | 0.77% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 100 | $171.45 | 12,936.0000 | 27,752,000 | 0.77% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 637 | $162.73 | 12,936.0000 | 27,752,000 | 4.69% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 786 | $63.55 | 13,722.0000 | 27,752,000 | 6.08% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 786 | $163.49 | 12,936.0000 | 27,752,000 | 5.73% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 1600 | $63.55 | 14,536.0000 | 27,752,000 | 12.37% | 0.01% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 1600 | $164.84 | 12,936.0000 | 27,752,000 | 11.01% | 0.01% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 200 | $63.55 | 13,136.0000 | 27,752,000 | 1.55% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 200 | $166.04 | 12,936.0000 | 27,752,000 | 1.52% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 300 | $63.55 | 13,236.0000 | 27,752,000 | 2.32% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 300 | $167.85 | 12,936.0000 | 27,752,000 | 2.27% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 1133 | $63.55 | 14,069.0000 | 27,752,000 | 8.76% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 1133 | $169.10 | 12,936.0000 | 27,752,000 | 8.05% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 210 | $63.55 | 13,146.0000 | 27,752,000 | 1.62% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 210 | $169.75 | 12,936.0000 | 27,752,000 | 1.60% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 134 | $63.55 | 13,070.0000 | 27,752,000 | 1.04% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 134 | $171.66 | 12,936.0000 | 27,752,000 | 1.03% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Stock Option (Right to Buy) | 2500 | $0.00 | 35,000.0000 | 27,752,000 | 6.67% | 0.01% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 30,000.0000 | 27,752,000 | 14.29% | 0.02% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 637 | $63.55 | 13,573.0000 | 27,752,000 | 4.92% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 648 | $63.55 | 13,584.0000 | 27,752,000 | 5.01% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 648 | $162.71 | 12,936.0000 | 27,752,000 | 4.77% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 900 | $63.55 | 13,836.0000 | 27,752,000 | 6.96% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 900 | $163.68 | 12,936.0000 | 27,752,000 | 6.50% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 1429 | $63.55 | 14,365.0000 | 27,752,000 | 11.05% | 0.01% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 1429 | $164.81 | 12,936.0000 | 27,752,000 | 9.95% | 0.01% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 300 | $63.55 | 13,236.0000 | 27,752,000 | 2.32% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 300 | $166.06 | 12,936.0000 | 27,752,000 | 2.27% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 300 | $63.55 | 13,236.0000 | 27,752,000 | 2.32% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 300 | $167.85 | 12,936.0000 | 27,752,000 | 2.27% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 1216 | $63.55 | 14,152.0000 | 27,752,000 | 9.40% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 1216 | $169.09 | 12,936.0000 | 27,752,000 | 8.59% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 117 | $63.55 | 13,053.0000 | 27,752,000 | 0.90% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 117 | $169.82 | 12,936.0000 | 27,752,000 | 0.90% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 90 | $63.55 | 13,026.0000 | 27,752,000 | 0.70% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 90 | $172.23 | 12,936.0000 | 27,752,000 | 0.69% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 5000 | $0.00 | 17,936.0000 | 27,752,000 | 38.65% | 0.02% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | F | Common Stock | 2314 | $163.08 | 15,622.0000 | 27,752,000 | 12.90% | 0.01% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 25,000.0000 | 27,752,000 | 16.67% | 0.02% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Performance Stock Units | 5000 | $0.00 | 5,000.0000 | 27,752,000 | 50.00% | 0.02% |
| Feb. 29, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | A | Performance Stock Units | 15000 | $0.00 | 15,000.0000 | 27,752,000 | 9999.99% | 0.05% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 523 | $63.55 | 13,459.0000 | 27,752,000 | 4.04% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 523 | $163.13 | 12,936.0000 | 27,752,000 | 3.89% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 744 | $63.55 | 13,680.0000 | 27,752,000 | 5.75% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 744 | $164.60 | 12,936.0000 | 27,752,000 | 5.44% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 130 | $63.55 | 13,066.0000 | 27,752,000 | 1.00% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 130 | $165.22 | 12,936.0000 | 27,752,000 | 0.99% | 0.00% |
| Feb. 28, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 100 | $63.55 | 13,036.0000 | 27,752,000 | 0.77% | 0.00% |
| Feb. 26, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 3087 | $140.00 | 12,556.0000 | 27,752,000 | 19.73% | 0.01% |
| Feb. 26, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 3087 | $52.26 | 15,643.0000 | 27,752,000 | 24.59% | 0.01% |
| Feb. 26, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 5000 | $52.26 | 17,556.0000 | 27,752,000 | 39.82% | 0.02% |
| Feb. 27, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Common Stock | 1913 | $52.26 | 12,936.0000 | 27,752,000 | 17.35% | 0.01% |
| Feb. 26, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | F | Common Stock | 1533 | $157.00 | 11,023.0000 | 27,752,000 | 12.21% | 0.01% |
| Feb. 26, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | S | Common Stock | 5000 | $135.00 | 12,556.0000 | 27,752,000 | 28.48% | 0.02% |
| Feb. 27, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Stock Option (Right to Buy) | 1913 | $0.00 | 0.0000 | 27,752,000 | 100.00% | 0.01% |
| Feb. 26, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Stock Option (Right to Buy) | 3087 | $0.00 | 1,913.0000 | 27,752,000 | 61.74% | 0.01% |
| Feb. 26, 2024 | Krystal Biotech, Inc. | $KRYS | ROMANO KATHRYN | Chief Accounting Officer | M | Stock Option (Right to Buy) | 5000 | $0.00 | 5,000.0000 | 27,752,000 | 50.00% | 0.02% |
| Jan. 22, 2024 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | M | Stock Option (Right to Buy) | 2500 | $0.00 | 10,000.0000 | 27,752,000 | 20.00% | 0.01% |
| Jan. 22, 2024 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | S | Common Stock | 2500 | $130.00 | 12,556.0000 | 27,752,000 | 16.60% | 0.01% |
| Jan. 22, 2024 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | M | Common Stock | 2500 | $52.26 | 15,056.0000 | 27,752,000 | 19.91% | 0.01% |
| May 22, 2023 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | M | Stock Option (Right to Buy) | 12500 | $0.00 | 12,500.0000 | 25,492,000 | 50.00% | 0.05% |
| May 22, 2023 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | M | Stock Option (Right to Buy) | 12500 | $0.00 | 37,500.0000 | 25,492,000 | 25.00% | 0.05% |
| May 22, 2023 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | S | Common Stock | 2521 | $105.80 | 12,556.0000 | 25,492,000 | 16.72% | 0.01% |
| May 22, 2023 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | M | Common Stock | 2570 | $52.26 | 15,126.0000 | 25,492,000 | 20.47% | 0.01% |
| May 19, 2023 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | S | Common Stock | 3428 | $95.08 | 12,556.0000 | 25,492,000 | 21.45% | 0.01% |
| May 19, 2023 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | S | Common Stock | 12500 | $95.04 | 15,984.0000 | 25,492,000 | 43.88% | 0.05% |
| May 19, 2023 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | M | Common Stock | 12500 | $52.26 | 28,484.0000 | 25,492,000 | 78.20% | 0.05% |
| May 19, 2023 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | S | Common Stock | 12500 | $95.05 | 15,984.0000 | 25,492,000 | 43.88% | 0.05% |
| May 19, 2023 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | M | Common Stock | 12500 | $52.26 | 28,484.0000 | 25,492,000 | 78.20% | 0.05% |
| May 22, 2023 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | M | Common Stock | 2521 | $52.26 | 15,077.0000 | 25,492,000 | 20.08% | 0.01% |
| May 22, 2023 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | S | Common Stock | 2570 | $106.81 | 12,556.0000 | 25,492,000 | 16.99% | 0.01% |
| May 22, 2023 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | M | Common Stock | 1300 | $52.26 | 13,856.0000 | 25,492,000 | 10.35% | 0.01% |
| May 22, 2023 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | S | Common Stock | 1300 | $107.88 | 12,556.0000 | 25,492,000 | 9.38% | 0.01% |
| May 22, 2023 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | M | Common Stock | 2955 | $52.26 | 15,511.0000 | 25,492,000 | 23.53% | 0.01% |
| May 22, 2023 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | S | Common Stock | 2955 | $109.17 | 12,556.0000 | 25,492,000 | 19.05% | 0.01% |
| May 22, 2023 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | M | Common Stock | 3154 | $52.26 | 15,710.0000 | 25,492,000 | 25.12% | 0.01% |
| May 22, 2023 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | S | Common Stock | 3154 | $109.99 | 12,556.0000 | 25,492,000 | 20.08% | 0.01% |
| May 22, 2023 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | M | Common Stock | 12500 | $63.55 | 25,056.0000 | 25,492,000 | 99.55% | 0.05% |
| May 22, 2023 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | S | Common Stock | 12500 | $110.00 | 12,556.0000 | 25,492,000 | 49.89% | 0.05% |
| May 19, 2023 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | M | Stock Option (Right to Buy) | 12500 | $0.00 | 37,500.0000 | 25,492,000 | 25.00% | 0.05% |
| May 19, 2023 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | M | Stock Option (Right to Buy) | 12500 | $0.00 | 25,000.0000 | 25,492,000 | 33.33% | 0.05% |
| Feb. 28, 2023 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | A | Performance Stock Units | 10000 | $0.00 | 10,000.0000 | 25,492,000 | 9999.99% | 0.04% |
| Feb. 28, 2023 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | A | Stock Option (Right to Buy) | 20000 | $0.00 | 20,000.0000 | 25,492,000 | 9999.99% | 0.08% |
| Feb. 26, 2023 | Krystal Biotech, Inc. | $KRYS | Romano Kathryn | Chief Accounting Officer | F | Common Stock | 2144 | $78.46 | 15,984.0000 | 25,492,000 | 11.83% | 0.01% |